The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis wit

The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis wit

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE

Durect (DRRX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate

Recent business highlights and updates:In July 2025, DURECT announced that it entered into an Agreem

Bausch Health will pay $1.75 per share plus up to $350 million in aggregate sales milestones Transac

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

Bausch Health Companies Inc. BHC on Tuesday agreed to indirectly acquire DURECT Corp DRRX, including

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating DURECT (NYSE: DRRX) for possible breache

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designa

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designa

Planning a registrational Phase 3 trial for larsucosterol in alcohol-associated hepatitis (AH) with

DURECT Corporation (NASDAQ:DRRX ) Q4 2024 Earnings Conference Call March 26, 2025 4:30 PM ET Company

Durect (DRRX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate

Larsucosterol Phase 2b AHFIRM trial results published in NEJM Evidence in January 2025 Additional AH

CUPERTINO, Calif. , March 19, 2025 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage b

CUPERTINO, Calif. , Feb. 4, 2025 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced t

The article presents new trial data, including subgroup analyses and liver biomarkers, which have gu

Durect (DRRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t

AFRM, ZNTL, IMTX, MRCY and DRRX have been added to the Zacks Rank #1 (Strong Buy) List on January 9,

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly los

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market tr

  On Wednesday, 311 stocks hit new 52-week lows.

  Friday's session saw 112 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.

  On Tuesday, 164 companies achieved new lows for the year.

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) rose 45% to $0.2890 in pre-market trading after

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

Companies Reporting Before The Bell • Cohen & Co (AMEX:COHN) is likely to report earnings for i

  On Tuesday, 31 stocks hit new 52-week lows.

  On Wednesday, 258 companies hit new 52-week lows.

  Tuesday's session saw 167 companies set new 52-week lows.

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on vol

Gainers

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesda